Bullock Wealth Management’s Organon & Co OGN Stock Holding History

Bullock Wealth Management’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.29K	Sell	317 -304	-49%	-$3.63K	﹤0.01%	509
2026 Q1	$3.81K	Sell	621 -176	-22%	-$1.32K	﹤0.01%	517
2025 Q4	$5.71K	Buy	797 +315	+65%	+$2.49K	﹤0.01%	464
2025 Q3	$5.29K	Buy	482 +35	+8%	+$343	﹤0.01%	481
2025 Q2	$4.49K	Buy	447 +132	+42%	+$1.36K	﹤0.01%	467
2025 Q1	$4.46K	Buy	315 +3	+1%	+$46	﹤0.01%	454
2024 Q4	$4.66K	Buy	312 +3	+1%	+$49	﹤0.01%	454
2024 Q3	$5.83K	Buy	309 +2	+0.7%	+$41	﹤0.01%	425
2024 Q2	$6.24K	Buy	307 +2	+0.7%	+$40	﹤0.01%	393
2024 Q1	$5.65K	Buy	+305	New	+$5.23K	﹤0.01%	407

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Bullock Wealth Management's OGN Position: Q2 2026 in Review

Bullock Wealth Management reduced its Organon & Co (OGN) stake by 49% in Q2 2026, selling an estimated $3.63K and leaving 317 shares worth $4.29K. The position accounts for ﹤0.01% of the portfolio, ranked #509.

Bullock Wealth Management first reported a position in OGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $6.24K in Q2 2024. 636 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Bullock Wealth Management held 317 shares of Organon & Co worth $4.29K as of Q2 2026.
Bullock Wealth Management sold 304 Organon & Co shares in Q2 2026, an estimated $3.63K.
Organon & Co made up ﹤0.01% of Bullock Wealth Management's portfolio in Q2 2026, its #509 holding.
Bullock Wealth Management first reported a position in Organon & Co in Q1 2024 and has held it in 10 quarters since.
Bullock Wealth Management's Organon & Co position peaked at $6.24K in Q2 2024.
636 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Bullock Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.